Thyroid function in hypertensives in South-South Nigeria

Background: Hypertension is the most common cardiovascular disease afflicting humans. It has been reported that hypertensive patients may have a tendency for impaired thyroid function but, these results have not always been confirmed. The aim of this study therefore was to determine the serum level of thyroid hormones in hypertensive subjects and any possible relationship between serum thyroid hormone levels and hypertension.Methods: Blood samples were consecutively obtained from One hundred and seventy (170) consenting subjects. One hundred were hypertensive subjects while seventy subjects were normotensive controls. Triiodothyronine (T3), Thyroxine (T4) and Thyroid stimulating hormone (TSH) were analyzed using ELISA kits. Data was analyzed using student “t” test and analysis of variance. The difference was considered statistically significant at p < 0.05.Results: The mean serum TSH value for hypertensive subjects was 3.01±2.42 µIu/ml and was significantly higher (p<0.0001) than that of the normotensive subjects (1.74±0.92 µIu/ml). Female hypertensive subjects had significantly higher (3.34±2.74 µIu/ml) mean TSH than the female normotensives with mean value of 1.79±0.86 µIu/ml (p<0.002). Mean TSH value for male hypertensive subjects was 2.78±2.4 µIu/ml and was significantly higher (p<0.007) than that of male normotensive subjects (1.72±0.96 µIu/ml). There were no significant differences in the mean serum T3 and T4 levels of hypertensives compared to the normotensives.Conclusions: It is concluded that the hypertensive subjects in this study required significantly higher (p<0.05) stimulation input, as measured from the level of thyroid stimulating hormone, to maintain the same level of thyroid hormones as their normotensive counterparts.

Thyroid function determinants in cord blood of Nigerian neonates

Background: Congenital hypothyroidism is one of the most prevalent endocrine disorders in the newborn; early diagnosis and treatment have resulted in normal growth and development in nearly all cases. Data on congenital hypothyroidism in Nigeria is limited, hence, this study aims at establishing the baseline values and prevalence of congenital hypothyroidism as a prelude to a screening centre in our locality.Methods: Cord blood samples were consecutively obtained from two hundred and eighty nine neonates born in the Delivery ward of the University of Maiduguri Teaching Hospital (UMTH). 152 (52.8%) of the neonates were males and 137 (47.2%) were females. Nineteen were preterm and 270 were full term. Triiodothyronine (T3), Thyroxine (T4) and Thyroid-stimulating hormone (TSH) were analyzed using ELISA kits. Data was analyzed using student “t” test and Pearson correlation coefficient. The difference was considered statistically significant at p 0.05). Triiodothyronine (T3) was undetectable in 75.8% of the neonates and very low in 24.2%. Twelve (4.2%) of the neonates had TSH levels >40µIU/ml with a mean TSH of 61.7±14.7 µIU/ml and a mean T4 of 7.7±3.7µg/dl.Conclusions: About 4.2% of neonates are at risk of congenital hypothyroidism with High TSH and low T4 values, T3 values are undetectable or very low in late prenatal life

AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders.

AMPA receptors (AMPARs) are tetrameric ligand-gated channels made up of combinations of GluA1-4 subunits encoded by GRIA1-4 genes. GluA2 has an especially important role because, following post-transcriptional editing at the Q607 site, it renders heteromultimeric AMPARs Ca2+-impermeable, with a linear relationship between current and trans-membrane voltage. Here, we report heterozygous de novo GRIA2 mutations in 28 unrelated patients with intellectual disability (ID) and neurodevelopmental abnormalities including autism spectrum disorder (ASD), Rett syndrome-like features, and seizures or developmental epileptic encephalopathy (DEE). In functional expression studies, mutations lead to a decrease in agonist-evoked current mediated by mutant subunits compared to wild-type channels. When GluA2 subunits are co-expressed with GluA1, most GRIA2 mutations cause a decreased current amplitude and some also affect voltage rectification. Our results show that de-novo variants in GRIA2 can cause neurodevelopmental disorders, complementing evidence that other genetic causes of ID, ASD and DEE also disrupt glutamatergic synaptic transmission

Thyroid function determinants in cord blood of Nigerian neonates

Background: Congenital hypothyroidism is one of the most prevalent endocrine disorders in the newborn; early diagnosis and treatment have resulted in normal growth and development in nearly all cases. Data on congenital hypothyroidism in Nigeria is limited, hence, this study aims at establishing the baseline values and prevalence of congenital hypothyroidism as a prelude to a screening centre in our locality.Methods: Cord blood samples were consecutively obtained from two hundred and eighty nine neonates born in the Delivery ward of the University of Maiduguri Teaching Hospital (UMTH). 152 (52.8%) of the neonates were males and 137 (47.2%) were females. Nineteen were preterm and 270 were full term. Triiodothyronine (T3), Thyroxine (T4) and Thyroid-stimulating hormone (TSH) were analyzed using ELISA kits. Data was analyzed using student “t” test and Pearson correlation coefficient. The difference was considered statistically significant at p &lt; 0.05.Results: The mean T3, T4 and TSH, in preterm compared with full term neonates were similar (p&gt;0.05). Triiodothyronine (T3) was undetectable in 75.8% of the neonates and very low in 24.2%. Twelve (4.2%) of the neonates had TSH levels &gt;40µIU/ml with a mean TSH of 61.7±14.7 µIU/ml and a mean T4 of 7.7±3.7µg/dl.Conclusions: About 4.2% of neonates are at risk of congenital hypothyroidism with High TSH and low T4 values, T3 values are undetectable or very low in late prenatal life

Thyroid function in hypertensives in South-South Nigeria

Background: Hypertension is the most common cardiovascular disease afflicting humans. It has been reported that hypertensive patients may have a tendency for impaired thyroid function but, these results have not always been confirmed. The aim of this study therefore was to determine the serum level of thyroid hormones in hypertensive subjects and any possible relationship between serum thyroid hormone levels and hypertension.Methods: Blood samples were consecutively obtained from One hundred and seventy (170) consenting subjects. One hundred were hypertensive subjects while seventy subjects were normotensive controls. Triiodothyronine (T3), Thyroxine (T4) and Thyroid stimulating hormone (TSH) were analyzed using ELISA kits. Data was analyzed using student “t” test and analysis of variance. The difference was considered statistically significant at p &lt; 0.05.Results: The mean serum TSH value for hypertensive subjects was 3.01±2.42 µIu/ml and was significantly higher (p&lt;0.0001) than that of the normotensive subjects (1.74±0.92 µIu/ml). Female hypertensive subjects had significantly higher (3.34±2.74 µIu/ml) mean TSH than the female normotensives with mean value of 1.79±0.86 µIu/ml (p&lt;0.002). Mean TSH value for male hypertensive subjects was 2.78±2.4 µIu/ml and was significantly higher (p&lt;0.007) than that of male normotensive subjects (1.72±0.96 µIu/ml). There were no significant differences in the mean serum T3 and T4 levels of hypertensives compared to the normotensives.Conclusions: It is concluded that the hypertensive subjects in this study required significantly higher (p&lt;0.05) stimulation input, as measured from the level of thyroid stimulating hormone, to maintain the same level of thyroid hormones as their normotensive counterparts.

Alterations to task positive and task negative networks during executive functioning in Mild Cognitive Impairment

Poor executive functioning increases risk of decline in Mild Cognitive Impairment (MCI). Executive functioning can be conceptualized within the framework of working memory. While some components are responsible for maintaining representations in working memory, the central executive is involved in the manipulation of information and creation of new representations. We aimed to examine the neural correlates of these components of working memory using a maintenance working memory and visuospatial reasoning task. Twenty-five patients with amnestic MCI and 19 elderly controls (EC) completed functional MRI during reasoning and maintenance working memory tasks. In MCI, maintenance working memory was associated with hypoactivation of right frontoparietal regions and hyperactivation of left prefrontal cortex, coupled with attenuation of default mode network (DMN) relative to EC. During reasoning, MCI showed hypoactivation of parietal regions, coupled with attenuation of anterior DMN and increased deactivation of posterior DMN relative to EC. Comparing the reasoning task to the maintenance working memory task yields the central executive. In MCI, the central executive showed hypoactivation of right parietal lobe and increased deactivation of posterior DMN compared to EC. Consistent with prior work on executive functioning, MCI show different neural circuitry during visuospatial reasoning, including changes to both task positive frontoparietal regions, as well as to deactivation patterns within the DMN. Both hyperactivation of task positive networks and increased deactivation of DMN may be compensatory. Keywords: Mild cognitive impairment, Executive functioning, Working memory, Prefrontal cortex, Default mode networ

The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome.

ObjectiveTo evaluate safety and tolerability and exploratory efficacy end points for gaboxadol (OV101) compared with placebo in individuals with Angelman syndrome (AS).MethodsGaboxadol is a highly selective orthosteric agonist that activates δ-subunit-containing extrasynaptic γ-aminobutyric acid type A (GABAA) receptors. In a multicenter, double-blind, placebo-controlled, parallel-group trial, adolescent and adult individuals with a molecular diagnosis of AS were randomized (1:1:1) to 1 of 3 dosing regimens for a duration of 12 weeks: placebo morning dose and gaboxadol 15 mg evening dose (qd), gaboxadol 10 mg morning dose and 15 mg evening dose (bid), or placebo morning and evening dose. Safety and tolerability were monitored throughout the study. Prespecified exploratory efficacy end points included adapted Clinical Global Impression-Severity and Clinical Global Impression-Improvement (CGI-I) scales, which documented the clinical severity at baseline and change after treatment, respectively.ResultsEighty-eight individuals were randomized. Of 87 individuals (aged 13-45 years) who received at least 1 dose of study drug, 78 (90%) completed the study. Most adverse events (AEs) were mild to moderate, and no life-threatening AEs were reported. Efficacy of gaboxadol, as measured by CGI-I improvement in an exploratory analysis, was observed in gaboxadol qd vs placebo (p = 0.0006).ConclusionAfter 12 weeks of treatment, gaboxadol was found to be generally well-tolerated with a favorable safety profile. The efficacy as measured by the AS-adapted CGI-I scale warrants further studies.Clinicaltrialsgov identifierNCT02996305.Classification of evidenceThis study provides Class I evidence that, for individuals with AS, gaboxadol is generally safe and well-tolerated

Overcoming Barriers in Conducting a Transatlantic Prostate Cancer Familial Study in Africa: Best Practice from the CaPTC Cohort Study

Conducting prostate cancer research, especially prospective data collection in Africa, has numerous challenges. Some of the difficulties stem from socio-cultural factors that consider sensitive topics about men’s health as taboo. Our primary aim was determine how to overcome barriers in conducting a transatlantic prostate cancer familial study in African males.Key research personnel of the CaPTC Transatlantic Prostate Cancer Familial Project were surveyed about their experiences in implementing the study. The data from the survey was analyzed using SPSS version 18. A total of 15 key study personnel responded to the survey. About 73% of the respondents reported that the participants requested a home or office visit rather than visit a data collection center. Eighty percent (80%) of the respondents reported that the participants had no preference for interviewer gender. The majority (80%) of the interviewers agreed that answers to questions about participants’ sexuality were most challenging to obtain, but with an in-depth explanation of the importance of the study and assurance of privacy, the answers were obtained. The best practice for engaging the community for research include community mobilization through sensitization visits and one-on-one talks, use of community ‘gatekeepers’, introduction by relatives, assurance of privacy of health data obtained, the use of incentives and a promise to give feedback on the results of the study both on a personal and community level

Towards the genome sequence of pea : a tribute to Mendel

BAPGEAPSIPea (Pisum sativum L.) was the original model organism for Mendel´s discovery of the laws of inheritance and kept this model status until the advent of molecular biology at the end of the 20th century. Pea is also one of the world’s oldest domesticated crops. It is currently the third most widely grown pulse crop, as its seeds serve as a protein-rich food for humans and livestock alike. While several legume species genome's draft sequences have been produced, progress in pea genomics has lagged behind largely as a consequence of its complex and large genome size. The pea genome is large (ca 4.45 Gb), probably resulting from recent expansion of retrotransposons followed by sequence diversification. The Pea Genome International Project has undertaken several complementary strategies in order to produce a high-quality draft sequence of the species. We will present how this draft sequence opens the way to renew strategies in pea breeding